All GLP-1s promote weight loss, but semaglutide (particularly at higher doses used for weight loss) and tirzepatide have demonstrated the most significant weight loss effects
Move your vials to the back of the middle shelf
Their findings were striking: AKD patients treated with GLP-1 RAs experienced lower rates of major adverse kidney events (MAKEs), which include complications like the need for dialysis, worsening kidney function, and even death due to kidney failure
Semax (ACTH(4-10) analogue) has the largest body of published clinical data, it is registered in Russia and Ukraine for stroke and cognitive impairment indications, but this data does not meet the evidentiary standards required for Western regulatory approval (independent randomisation, blinding, and pre-specified primary endpoints)
The ability to present your unique case, negotiate settlements on your terms, and potentially secure higher compensation makes individual lawsuits an appealing option for many Ozempic users